Prothena Corp. (PRTA) – Trading Halts
-
Prothena Corp. (PRTA) to Resume Trading at 4:45 p.m.
-
Prothena Corp. (PRTA) Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA
-
-
-
-
-
-
-
-
-
-
Back to PRTA Stock Lookup